Biofrontera, Inc. (BFRI)
0.7891
+0.01
(+1.04%)
USD |
NASDAQ |
Oct 23, 16:00
0.7801
-0.01
(-1.14%)
After-Hours: 20:00
Biofrontera Net Income (Quarterly) : -0.604M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.604M |
| March 31, 2026 | -4.752M |
| December 31, 2025 | 5.64M |
| September 30, 2025 | -6.649M |
| June 30, 2025 | -5.324M |
| March 31, 2025 | -4.203M |
| December 31, 2024 | -1.396M |
| September 30, 2024 | -5.669M |
| June 30, 2024 | -0.257M |
| March 31, 2024 | -10.44M |
| December 31, 2023 | 3.526M |
| September 30, 2023 | -6.342M |
| June 30, 2023 | -9.837M |
| Date | Value |
|---|---|
| March 31, 2023 | -7.478M |
| December 31, 2022 | -2.785M |
| September 30, 2022 | -2.566M |
| June 30, 2022 | -0.85M |
| March 31, 2022 | 5.561M |
| December 31, 2021 | -14.50M |
| September 30, 2021 | -16.01M |
| June 30, 2021 | -3.661M |
| March 31, 2021 | -3.534M |
| September 30, 2020 | -2.985M |
| June 30, 2020 | -3.712M |
| March 31, 2020 | -4.104M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 23.00M |
| Corcept Therapeutics, Inc. | 42.14M |
| Veru, Inc. | -6.988M |
| Johnson & Johnson | 210.00M |
| Eli Lilly & Co. | 7.095B |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 12.00M |
| Total Expenses (Quarterly) | 12.61M |
| EPS Diluted (Quarterly) | -0.0467 |
| Enterprise Value | 14.05M |
| Gross Profit Margin (Quarterly) | 91.59% |
| Profit Margin (Quarterly) | -5.03% |
| Earnings Yield | -74.29% |
| Normalized Earnings Yield | -35.80 |